Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

V

VKTX

Viking Therapeutics Inc

35.98

Aug 19 • 3:59 PM ET +2.61 (7.82%)

36.00

Aftermarket • 7:59 PM ET +0.02 (0.06%)

Healthcare Biotechnology USA Mid NASD

Peers: MDGL AXSM ACAD KROS RYTM BMRN KYMR INCY CRNX NBIX

| Held by: XBI VTI VB VBK VXF SCHA IWR DFMC VHT IWD

Scroll to Statements

Index	-
Market Cap	4.20B
Enterprise Value	3.70B
Income	-534.80M
Sales	0.00M
Book/sh	3.50
Cash/sh	4.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	53
IPO	Apr 29, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	10.28
P/C	8.37
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	4.72
Current Ratio	4.72
Debt/Eq	0.01
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-4.66
EPS next Y	-4.39
EPS next Q	-1.07
EPS this Y	-44.59%
EPS next Y	4.78%
EPS next 5Y	-4.68%
EPS past 3/5Y	-52.71% -42.46%
Sales past 3/5Y	- -
EPS Y/Y TTM	-203.77%
Sales Y/Y TTM	-
EPS Q/Q	-88.32%
Sales Q/Q	-
Earnings	Jul 29 AMC
EPS/Sales Surpr.	10.77% -

Insider Own	3.19%
Insider Trans	-4.70%
Inst Own	65.09%
Inst Trans	-0.23%
ROA	-79.24%
ROE	-88.85%
ROIC	-129.73%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.58%
SMA50	3.22%
SMA200	6.61%
Trades

Shs Outstand	116.65M
Shs Float	112.93M
Short Float	19.96%
Short Ratio	10.01
Short Interest	22.54M
52W High	43.15 -16.62%
52W Low	22.96 56.71%
Volatility	4.13% 4.30%
ATR (14)	1.58
RSI (14)	57.48
Beta	0.68
Rel Volume	1.19
Avg Volume	2.25M
Volume	2,686,216

Perf Week	5.76%
Perf Month	-5.19%
Perf Quarter	26.69%
Perf Half Y	19.34%
Perf YTD	2.27%
Perf Year	47.70%
Perf 3Y	157.37%
Perf 5Y	544.80%
Perf 10Y	2755.56%
Recom	1.20
Target Price	93.11
Prev Close	33.37
Price	35.98
Change %	7.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)